Press Releases

Grab your esky and your stretchy pants – the Scenic Rim Farm Gate Trail is THIS SUNDAY!!

Overflowing larders right on the farm, freshly picked produce from a paddock you can see, jams and chutneys made with love, olives and cheese, honey and garlic, carrots for days, farm walks, wine tastings, lamb pats, alpaca cuddles and goat giggles, these are just some of the highlights of the Scenic Rim Farm Gate Trail that’s happening THIS SUNDAY April 28 from 9am to 3pm.

... (continue reading...)

VANCOUVER, BC, April 24, 2024 /CNW/ -

TSX VENTURE COMPANIES

None today.

24/04/24 - TSX Venture Exchange Bulletins

TSX VENTURE COMPANIES

BULLETIN V2024-1192

AUKA CAPITAL CORP. ("AUK.P") BULLETIN TYPE:  HaltBULLETIN DATE:  April 24, 2024TSX Venture Tier 2 Company 

Effective at 5:10 a.m. PST, April 24, 2024, trading in the shares of the Company was halted, pending news; this regulatory halt is imposed by Investment Industry Regulatory Organization of Canada, the... (continue reading...)

NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Marex Group plc (“Marex”), the diversified global financial services platform, today announces the pricing of its initial public offering (the “IPO”), at $19.00 per share. A total of 15,384,615 ordinary shares are being offered, of which 3,846,153 shares are being offered by Marex and 11,538,462 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Marex will not receive any... (continue reading...)

NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Marex Group plc (“Marex”), the diversified global financial services platform, today announces the pricing of its initial public offering (the “IPO”), at $19.00 per share. A total of 15,384,615 ordinary shares are being offered, of which 3,846,153 shares are being offered by Marex and 11,538,462 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Marex will not receive any... (continue reading...)

Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases

Transaction requires court approval, with confirmation expected on May 6, 2024

BURLINGTON, N.C., April 24, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the... (continue reading...)